Deal Snapshot
AURORA CANNABIS TO ACQUIRE MEDRELEAF IN CDN 3.2BN STOCK TRANSACTION
Wednesday 16 May 2018

Canada-based Aurora Cannabis Inc. (TSX: ACB) has entered into a definitive agreement to acquire all issued and outstanding common shares of Canada-based cannabis company MedReleaf Corp. (TSX: LEAF) in an all-share transaction valued at approximately CDN 3.2bn (USD 2.5bn), the company said.
Under the terms of the agreement, holders of MedReleaf common shares will receive 3.575 common shares of Aurora for each MedReleaf common share held. Upon completion of the transaction, existing Aurora and MedReleaf shareholders would own approximately 61% and 39% of the pro forma company, respectively, on a fully diluted basis.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 16/05/2018
Target: MedReleaf Corp
Country: Canada
Deal Size: 2.5bn (USD)
Sector: Consumer Products
Type: Corporate acquisition
Financing: Stock
Status: Agreed
Vendor:
Buyer: Aurora Cannabis
Buyer Advisor: BMO Capital Markets , Davies,  Ward Phillips and Vineberg
Comment:


Options